Human Thrombin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066410
  • May 2021
  • Pharmaceuticals
  • 124 Pages
The Human Thrombin Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered AMRESCO Inc., Baxter International, Inc., Bayer AG, BD Biosciences, CSL Behring, Life Technologies Corporation, Pfizer Inc., PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Human Thrombin market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Human Thrombin market is expected to attain Pre COVID-19 levels by mid-2022.

Human Thrombin Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Human Thrombin market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Human Thrombin Market Competitive and Premeditated Analysis
In the Human Thrombin report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Human Thrombin research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Human Thrombin Market:
The Human Thrombin market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. AMRESCO Inc., Baxter International, Inc., Bayer AG, BD Biosciences, CSL Behring, Life Technologies Corporation, Pfizer Inc., PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB

The Human Thrombin market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Human Thrombin Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Human Thrombin market:
by Product
Bovine Thrombin
Human Thrombin
Recombinant Thrombin
Dosage Form
Powder Form
Solution Form
Others
End User
Hospitals
Diagnostics Centers and Clinics
Academics and Research Institutes

Regional Analysis of the Human Thrombin market:
The Human Thrombin market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Human Thrombin report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Human Thrombin market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Human Thrombin market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Human Thrombin market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Human Thrombin market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Human Thrombin market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Human Thrombin market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Human Thrombin market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Human Thrombin market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • AMRESCO Inc.
  • Baxter International, Inc.
  • Bayer AG
  • BD Biosciences
  • CSL Behring
  • Life Technologies Corporation
  • Pfizer Inc.
  • PromoCell GmbH
  • Sigma-Aldrich Corporation
  • Vitrolife AB
  • Bovine Thrombin
  • Human Thrombin
  • Recombinant Thrombin
  • Hospitals
  • Diagnostics Centers and Clinics
  • Academics and Research Institutes

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Human Thrombin Market Snapshot
          2.1.1. Global Human Thrombin Market By Product,2019
               2.1.1.1.Bovine Thrombin
               2.1.1.2.Human Thrombin
               2.1.1.3.Recombinant Thrombin
          2.1.2. Global Human Thrombin Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Diagnostics Centers and Clinics
               2.1.2.3.Academics and Research Institutes
          2.1.3. Global Human Thrombin Market By End-use,2019
          2.1.4. Global Human Thrombin Market By Geography,2019

3. Global Human Thrombin Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Human Thrombin Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Human Thrombin Market Size (US$), By Product, 2018 – 2028

5. Global Human Thrombin Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Human Thrombin Market Size (US$), By End User, 2018 – 2028

6. Global Human Thrombin Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Human Thrombin Market Size (US$), By End-use, 2018 – 2028

7. Global Human Thrombin Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Human Thrombin Market Analysis, 2018 – 2028 
          7.2.1. North America Human Thrombin Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Human Thrombin Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Human Thrombin Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Human Thrombin Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Human Thrombin Market Analysis, 2018 – 2028 
          7.3.1.  Europe Human Thrombin Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Human Thrombin Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Human Thrombin Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Human Thrombin Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Human Thrombin Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Human Thrombin Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Human Thrombin Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Human Thrombin Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Human Thrombin Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Human Thrombin Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Human Thrombin Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Human Thrombin Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Human Thrombin Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Human Thrombin Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Human Thrombin Market Analysis, 2018 – 2028 
          7.6.1.  MEA Human Thrombin Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Human Thrombin Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Human Thrombin Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Human Thrombin Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Human Thrombin Providers
        8.4.1 AMRESCO Inc.
                8.4.1.1 Business Description
                8.4.1.2 AMRESCO Inc. Geographic Operations
                8.4.1.3 AMRESCO Inc. Financial Information
                8.4.1.4 AMRESCO Inc. Product Positions/Portfolio
                8.4.1.5 AMRESCO Inc. Key Developments
        8.4.2 Baxter International, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Baxter International, Inc. Geographic Operations
                8.4.2.3 Baxter International, Inc. Financial Information
                8.4.2.4 Baxter International, Inc. Product Positions/Portfolio
                8.4.2.5 Baxter International, Inc. Key Developments
        8.4.3 Bayer AG
                8.4.3.1 Business Description
                8.4.3.2 Bayer AG Geographic Operations
                8.4.3.3 Bayer AG Financial Information
                8.4.3.4 Bayer AG Product Positions/Portfolio
                8.4.3.5 Bayer AG Key Developments
        8.4.4 BD Biosciences
                8.4.4.1 Business Description
                8.4.4.2 BD Biosciences Geographic Operations
                8.4.4.3 BD Biosciences Financial Information
                8.4.4.4 BD Biosciences Product Positions/Portfolio
                8.4.4.5 BD Biosciences Key Developments
        8.4.5 CSL Behring
                8.4.5.1 Business Description
                8.4.5.2 CSL Behring Geographic Operations
                8.4.5.3 CSL Behring Financial Information
                8.4.5.4 CSL Behring Product Positions/Portfolio
                8.4.5.5 CSL Behring Key Developments
        8.4.6 Life Technologies Corporation
                8.4.6.1 Business Description
                8.4.6.2 Life Technologies Corporation Geographic Operations
                8.4.6.3 Life Technologies Corporation Financial Information
                8.4.6.4 Life Technologies Corporation Product Positions/Portfolio
                8.4.6.5 Life Technologies Corporation Key Developments
        8.4.7 Pfizer Inc.
                8.4.7.1 Business Description
                8.4.7.2 Pfizer Inc. Geographic Operations
                8.4.7.3 Pfizer Inc. Financial Information
                8.4.7.4 Pfizer Inc. Product Positions/Portfolio
                8.4.7.5 Pfizer Inc. Key Developments
        8.4.8 PromoCell GmbH
                8.4.8.1 Business Description
                8.4.8.2 PromoCell GmbH Geographic Operations
                8.4.8.3 PromoCell GmbH Financial Information
                8.4.8.4 PromoCell GmbH Product Positions/Portfolio
                8.4.8.5 PromoCell GmbH Key Developments
        8.4.9 Sigma-Aldrich Corporation
                8.4.9.1 Business Description
                8.4.9.2 Sigma-Aldrich Corporation Geographic Operations
                8.4.9.3 Sigma-Aldrich Corporation Financial Information
                8.4.9.4 Sigma-Aldrich Corporation Product Positions/Portfolio
                8.4.9.5 Sigma-Aldrich Corporation Key Developments
        8.4.10 Vitrolife AB
                8.4.10.1 Business Description
                8.4.10.2 Vitrolife AB Geographic Operations
                8.4.10.3 Vitrolife AB Financial Information
                8.4.10.4 Vitrolife AB Product Positions/Portfolio
                8.4.10.5 Vitrolife AB Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Human Thrombin Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Human Thrombin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Human Thrombin Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Human Thrombin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Human Thrombin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Human Thrombin Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Human Thrombin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Human Thrombin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Human Thrombin Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Human Thrombin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Human Thrombin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Human Thrombin Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Human Thrombin Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Human Thrombin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Human Thrombin Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Human Thrombin Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Human Thrombin: Market Segmentation 
FIG. 2 Global Human Thrombin Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Human Thrombin Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Human Thrombin Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Human Thrombin Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Human Thrombin Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Human Thrombin Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Human Thrombin Providers, 2019
FIG. 11 Global Human Thrombin Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Human Thrombin Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Human Thrombin Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Human Thrombin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Human Thrombin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Human Thrombin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Human Thrombin Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Human Thrombin Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Human Thrombin market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Human Thrombin Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Human Thrombin Market Value, By Segment1, 2018 – 2028
TABLE  North America Human Thrombin Market Value, By Segment2, 2018 – 2028
TABLE  North America Human Thrombin Market Value, By Country, 2018 – 2028
TABLE  Europe Human Thrombin Market Value, By Segment1, 2018 – 2028
TABLE  Europe Human Thrombin Market Value, By Segment2, 2018 – 2028
TABLE  Europe Human Thrombin Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Human Thrombin Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Human Thrombin Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Human Thrombin Market Value, By Country, 2018 – 2028
TABLE  Latin America Human Thrombin Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Human Thrombin Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Human Thrombin Market Value, By Country, 2018 – 2028
TABLE  MEA Human Thrombin Market Value, By Segment1, 2018 – 2028
TABLE  MEA Human Thrombin Market Value, By Segment2, 2018 – 2028
TABLE  MEA Human Thrombin Market Value, By Country, 2018 – 2028
TABLE  AMRESCO Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Baxter International, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BD Biosciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CSL Behring: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Life Technologies Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  PromoCell GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sigma-Aldrich Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vitrolife AB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Human Thrombin Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Human Thrombin Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Human Thrombin Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Human Thrombin Market, By Geography, 2019 (US$ Mn)
FIG.  Global Human Thrombin Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Human Thrombin Providers, 2016
FIG.  Global Human Thrombin Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Recombinant Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Human Thrombin Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Diagnostics Centers and Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Academics and Research Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Human Thrombin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Human Thrombin Market Value, 2018 – 2028, (US$ Mn)